Clinical Trials

FLŌ Life Sciences has demonstrated the effectiveness of its QuantumCCM™ formulation in inhibiting viral infection, including COVID-19 Virus (SARS-CoV-2), and is working diligently to determine its efficacy for preventing and treating COVID-19 infections.

At present, FLŌ Life Sciences is carrying out:

A ) Clinical Trial for Treatment of COVID-19
• Prevention of moderate to severe COVID-19 diseases
• Reduce infectivity period (Lower Quarantine)

B ) Clinical Trial for Prevention of COVID-19
• Oral Spray for prophylaxis in at-risk populations
• Prevent further infectivity for those in quarantine

C ) Clinical Trial for Category 4 and 5 Patients
• Reduce morbidity and mortality
• Reduce load on ICU beds